The White House announced on Thursday the purchase of 150 million rapid coronavirus tests from Abbott Laboratories, which a day earlier was granted emergency approval from the Food and Drug Administration for a new $5 test that can be run in 15 minutes.
The $750 million deal with Abbott came just days after the Centers for Disease Control and Prevention, reportedly under pressure from top Trump administration officials, moved to discourage testing for people who don’t show Covid-19 symptoms — even if they’ve recently been exposed to the virus. Many public health experts denounced that decision, saying it would make it harder to track and fight the virus.
Described as “rapid, reliable, highly portable and affordable” in a statement released on Wednesday, Abbott’s new device, called the BinaxNOW Covid-19 Ag Card, is a bit like a pregnancy test. It is meant to detect pieces of coronavirus proteins on a credit-card-size device that doesn’t require laboratory equipment.
Read more at New York Times.